OptimizeRx's market cap is currently $114.03M. The company's EPS TTM is $-1.325; its P/E ratio is ―; OptimizeRx is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $0.27. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 71.52M	$ 62.45M	$ 61.29M	$ 43.31M	$ 24.60M
Gross Profit	$ 42.90M	$ 38.97M	$ 35.64M	$ 24.11M	$ 15.44M
Operating Income	$ -26.40M	$ -12.29M	$ 482.23K	$ -1.89M	$ -3.69M
EBITDA	$ -21.31M	$ -9.42M	$ 2.33M	$ -59.43K	$ -2.76M
Net Income	$ -17.57M	$ -10.59M	$ 273.93K	$ -2.38M	$ -3.14M
Balance Sheet
Cash & Short-Term Investments	$ 13.85M	$ 74.14M	$ 84.68M	$ 10.52M	$ 18.85M
Total Assets	$ 183.37M	$ 134.65M	$ 140.99M	$ 60.33M	$ 56.64M
Total Debt	$ 36.82M	$ 234.43K	$ 327.71K	$ 448.75K	$ 564.18K
Net Debt	$ 22.97M	$ -17.97M	$ -84.35M	$ -10.07M	$ -18.29M
Total Liabilities	$ 56.82M	$ 8.54M	$ 9.61M	$ 10.35M	$ 11.78M
Stockholders' Equity	$ 126.55M	$ 126.11M	$ 131.38M	$ 49.97M	$ 44.86M
Cash Flow
Free Cash Flow	$ -8.11M	$ 10.41M	$ 240.04K	$ -6.44M	$ -3.25M
Operating Cash Flow	$ -7.24M	$ 10.65M	$ 726.04K	$ -6.31M	$ -1.66M
Investing Cash Flow	$ -25.34M	$ -58.18M	$ -486.00K	$ -124.72K	$ -10.58M
Financing Cash Flow	$ 28.22M	$ -18.95M	$ 73.92M	$ -1.90M	$ 22.18M

Currency in USD

OptimizeRx Earnings and Revenue History

Income Statement >

OptimizeRx Debt to Assets

Balance Sheet >

OptimizeRx Cash Flow

Cash Flow >

OptimizeRx Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing